PuSH - Publication Server of Helmholtz Zentrum München

Iskra, S. ; Kalla, M. ; Delecluse, H.J.* ; Hammerschmidt, W. ; Moosmann, A.

Toll-like receptor agonists synergistically increase proliferation and activation of B cells by Epstein-Barr virus.

J. Virol. 84, 3612-3623 (2010)
Publ. Version/Full Text Volltext DOI PMC
Free by publisher
Open Access Green as soon as Postprint is submitted to ZB.
Epstein-Barr virus (EBV) efficiently drives proliferation of human primary B cells in vitro, a process relevant for human diseases such as infectious mononucleosis and posttransplant lymphoproliferative disease. Human B-cell proliferation is also driven by ligands of Toll-like receptors (TLRs), notably viral or bacterial DNA containing unmethylated CpG dinucleotides, which triggers TLR9. Here we quantitatively investigated how TLR stimuli influence EBV-driven B-cell proliferation and expression of effector molecules. CpG DNA synergistically increased EBV-driven proliferation and transformation, T-cell costimulatory molecules, and early production of interleukin-6. CpG DNA alone activated only memory B cells, but CpG DNA enhanced EBV-mediated transformation of both memory and naive B cells. Ligands for TLR2 or TLR7/8 or whole bacteria had a weaker but still superadditive effect on B-cell transformation. Additionally, CpG DNA facilitated the release of transforming virus by established EBV-infected lymphoblastoid cell lines. These results suggest that the proliferation of EBV-infected B cells and their capability to interact with immune effector cells may be directly influenced by components of bacteria or other microbes present at the site of infection.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Human monoclonal-antibodies; Autocrine growth-factor; Infectious-mononucleosis; Anaerobic-bacteria; Signaling pathway; CPG DNA; RIG-I; Expression; EBV; Transformation
ISSN (print) / ISBN 0022-538X
e-ISSN 1098-5514
Quellenangaben Volume: 84, Issue: 7, Pages: 3612-3623 Article Number: , Supplement: ,
Publisher American Society for Microbiology (ASM)
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Research Unit Gene Vector (AGV)
CCG Molecular Oncology (AGV-KON)